CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 115 filers reported holding CARDLYTICS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,110,695 | +161.1% | 1,218,830 | 0.0% | 10.97% | +137.2% |
Q2 2023 | $7,703,006 | +86.2% | 1,218,830 | 0.0% | 4.62% | +26.6% |
Q1 2023 | $4,137,928 | -41.3% | 1,218,830 | 0.0% | 3.65% | -55.2% |
Q4 2022 | $7,044,837 | -38.5% | 1,218,830 | 0.0% | 8.15% | -0.1% |
Q3 2022 | $11,457,000 | -57.9% | 1,218,830 | 0.0% | 8.16% | -47.8% |
Q2 2022 | $27,192,000 | -59.4% | 1,218,830 | 0.0% | 15.61% | -6.2% |
Q1 2022 | $67,011,000 | -18.7% | 1,218,830 | -2.2% | 16.64% | +29.6% |
Q4 2021 | $82,403,000 | -16.6% | 1,246,830 | +5.9% | 12.84% | -4.7% |
Q3 2021 | $98,783,000 | -30.9% | 1,176,830 | +4.4% | 13.48% | -21.3% |
Q2 2021 | $143,029,000 | +27.6% | 1,126,830 | +10.3% | 17.12% | +11.8% |
Q1 2021 | $112,095,000 | -23.2% | 1,021,830 | 0.0% | 15.31% | -28.4% |
Q4 2020 | $145,887,000 | +87.9% | 1,021,830 | -7.1% | 21.39% | +89.3% |
Q3 2020 | $77,627,000 | +22.3% | 1,100,000 | +21.3% | 11.30% | -9.8% |
Q2 2020 | $63,473,000 | +142.1% | 907,018 | +20.9% | 12.52% | +22.2% |
Q1 2020 | $26,220,000 | – | 750,000 | – | 10.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAS Investment Partners, LLC | 2,821,710 | $177,373,000 | 29.17% |
Antipodean Advisors LLC | 656,000 | $41,236,000 | 23.59% |
BRIGHTLIGHT CAPITAL MANAGEMENT LP | 272,900 | $17,154,000 | 12.97% |
Oakcliff Capital Partners, LP | 281,064 | $17,668,000 | 10.54% |
Polaris Venture Management Co. V, L.L.C. | 200,000 | $12,572,000 | 9.14% |
Covey Capital Advisors, LLC | 82,947 | $5,214,000 | 5.63% |
683 Capital Management, LLC | 575,000 | $36,145,000 | 4.13% |
JS Capital Management LLC | 455,000 | $28,601,000 | 3.30% |
CROSSLINK CAPITAL INC | 152,086 | $9,560,000 | 2.17% |
Pier Capital, LLC | 125,692 | $7,901,000 | 1.29% |